AUD 0.05
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 46.98 Million AUD | -31.64% |
2023 | 68.73 Million AUD | 17.1% |
2022 | 58.69 Million AUD | 71.61% |
2021 | 34.2 Million AUD | 3.45% |
2020 | 33.06 Million AUD | 46.42% |
2019 | 22.58 Million AUD | -45.68% |
2018 | 41.56 Million AUD | -35.39% |
2017 | 64.34 Million AUD | -28.96% |
2016 | 90.57 Million AUD | 138.86% |
2015 | 37.91 Million AUD | 153.49% |
2014 | 14.95 Million AUD | 26.08% |
2013 | 11.86 Million AUD | -39.51% |
2012 | 19.61 Million AUD | -13.99% |
2011 | 22.8 Million AUD | -8.45% |
2010 | 24.91 Million AUD | 90.18% |
2009 | 13.09 Million AUD | -9.76% |
2008 | 14.51 Million AUD | -33.38% |
2007 | 21.78 Million AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 58.59 Million AUD | 0.0% |
2024 Q4 | 46.98 Million AUD | 0.0% |
2024 FY | 46.98 Million AUD | -31.64% |
2023 Q2 | 48.22 Million AUD | 0.0% |
2023 Q4 | 68.73 Million AUD | 0.0% |
2023 FY | 68.73 Million AUD | 17.1% |
2022 Q2 | 67.48 Million AUD | 0.0% |
2022 Q4 | 58.69 Million AUD | 0.0% |
2022 FY | 58.69 Million AUD | 71.61% |
2021 FY | 34.2 Million AUD | 3.45% |
2021 Q4 | 34.2 Million AUD | 0.0% |
2021 Q2 | 31.39 Million AUD | 0.0% |
2020 FY | 33.06 Million AUD | 46.42% |
2020 Q2 | 24.63 Million AUD | 0.0% |
2020 Q4 | 33.06 Million AUD | 0.0% |
2019 Q2 | 31.57 Million AUD | 0.0% |
2019 Q4 | 22.58 Million AUD | 0.0% |
2019 FY | 22.58 Million AUD | -45.68% |
2018 FY | 41.56 Million AUD | -35.39% |
2018 Q4 | 41.56 Million AUD | 0.0% |
2018 Q2 | 49.9 Million AUD | 0.0% |
2017 Q4 | 64.34 Million AUD | 0.0% |
2017 Q2 | 80.38 Million AUD | 0.0% |
2017 FY | 64.34 Million AUD | -28.96% |
2016 FY | 90.57 Million AUD | 138.86% |
2016 Q4 | 90.57 Million AUD | 0.0% |
2016 Q2 | 30.62 Million AUD | 0.0% |
2015 FY | 37.91 Million AUD | 153.49% |
2015 Q2 | 43.1 Million AUD | 0.0% |
2015 Q4 | 37.91 Million AUD | 0.0% |
2014 Q4 | 14.95 Million AUD | 0.0% |
2014 FY | 14.95 Million AUD | 26.08% |
2014 Q2 | 8.93 Million AUD | 0.0% |
2013 Q2 | 13.96 Million AUD | 0.0% |
2013 Q4 | 11.86 Million AUD | 0.0% |
2013 FY | 11.86 Million AUD | -39.51% |
2012 Q4 | 19.61 Million AUD | 0.0% |
2012 FY | 19.61 Million AUD | -13.99% |
2011 FY | 22.8 Million AUD | -8.45% |
2011 Q4 | 22.8 Million AUD | 0.0% |
2010 Q4 | 24.91 Million AUD | 0.0% |
2010 FY | 24.91 Million AUD | 90.18% |
2009 Q4 | 13.09 Million AUD | 0.0% |
2009 FY | 13.09 Million AUD | -9.76% |
2008 FY | 14.51 Million AUD | -33.38% |
2008 Q4 | 14.51 Million AUD | 0.0% |
2007 FY | 21.78 Million AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
4DMedical Limited | 120.01 Million AUD | 60.85% |
Adherium Limited | 9.88 Million AUD | -375.223% |
Aroa Biosurgery Limited | 101.82 Million AUD | 53.855% |
Atomo Diagnostics Limited | 11.37 Million AUD | -312.918% |
Anteris Technologies Ltd | 45.7 Million AUD | -2.811% |
Control Bionics Limited | 9.02 Million AUD | -420.487% |
CardieX Limited | 12.64 Million AUD | -271.437% |
Compumedics Limited | 40.35 Million AUD | -16.423% |
Cochlear Limited | 2.74 Billion AUD | 98.288% |
CleanSpace Holdings Limited | 26.05 Million AUD | -80.357% |
Cyclopharm Limited | 45.91 Million AUD | -2.334% |
EMVision Medical Devices Ltd | 23.97 Million AUD | -96.009% |
Nova Eye Medical Limited | 29.88 Million AUD | -57.238% |
HeraMED Limited | 2.95 Million AUD | -1491.617% |
Imricor Medical Systems, Inc. | 12.17 Million AUD | -285.889% |
InhaleRx Limited | 1.57 Million AUD | -2879.674% |
LBT Innovations Limited | 7.93 Million AUD | -492.435% |
Micro-X Limited | 26.89 Million AUD | -74.702% |
Neurotech International Limited | 12.21 Million AUD | -284.709% |
OncoSil Medical Limited | 6.71 Million AUD | -599.363% |
PolyNovo Limited | 109.16 Million AUD | 56.96% |
Respiri Limited | 6.19 Million AUD | -658.951% |
SomnoMed Limited | 69.8 Million AUD | 32.689% |
Universal Biosensors, Inc. | 30.12 Million AUD | -55.994% |
Uscom Limited | 5.13 Million AUD | -815.081% |
Visioneering Technologies, Inc. | 11.2 Million AUD | -319.316% |